etoposide has been researched along with Abnormalities, Drug-Induced in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bláha, L; Isidori, M; Piscitelli, C; Russo, C; Smutná, M | 1 |
Bacci, G; Longhi, A; Macchiagodena, M; Vitali, G | 1 |
Marchetti, F; Wyrobek, AJ | 1 |
Borovskaya, TG; Gol'dberg, VE; Pakhomova, AV; Perova, AV; Shchemerova, YA; Timina, EA | 1 |
Gonzalez-Gonzalez, A; Pinilla, J; Requena, A; Velasco, JG | 1 |
Imai, K; Nagao, T; Saito, Y; Yoshimura, S | 1 |
Botkin, C; Knutsen, T; Sieber, SM; Whang-Peng, J | 1 |
Mirkes, PE; Zwelling, LA | 1 |
8 other study(ies) available for etoposide and Abnormalities, Drug-Induced
Article | Year |
---|---|
Teratogenic effects of five anticancer drugs on Xenopus laevis embryos.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Biological Assay; Capecitabine; Cisplatin; Embryo, Nonmammalian; Embryonic Development; Etoposide; Fluorouracil; Imatinib Mesylate; Teratogens; Toxicity Tests; Xenopus laevis | 2016 |
Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant, Newborn; Italy; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Oligospermia; Osteosarcoma; Puberty; Semen Preservation; Sperm Count; Surveys and Questionnaires | 2003 |
PAINT/DAPI analysis of mouse zygotes to detect paternally transmitted chromosomal aberrations.
Topics: Abnormalities, Drug-Induced; Acrylamide; Animals; Chromosome Aberrations; Etoposide; Female; Fluorescent Dyes; Genetic Techniques; In Situ Hybridization, Fluorescence; Indoles; Male; Mice; Paternal Exposure; Spermatocytes; Spermatozoa; Time Factors; Zygote | 2003 |
Evaluation of the progeny of rats treated with topoisomerase II inhibitor vepesid.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Antineoplastic Agents, Phytogenic; Etoposide; Female; Fetal Death; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Time Factors; Topoisomerase II Inhibitors | 2006 |
Acute leukemia during pregnancy: obstetric management and perinatal outcome of two cases.
Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Female; Humans; Leukemia, Promyelocytic, Acute; Mitoxantrone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Recurrence; Thioguanine | 1995 |
Developmental toxicity of the topoisomerase inhibitor, etoposide, in rabbits after intravenous administration.
Topics: Abnormalities, Drug-Induced; Animals; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Enzyme Inhibitors; Etoposide; Female; Liver; Maternal-Fetal Exchange; Pregnancy; Rabbits; Telencephalon; Teratogens; Topoisomerase I Inhibitors | 1999 |
Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Cells, Cultured; Chromosome Aberrations; Chromosomes; Colchicine; Etoposide; Female; Gestational Age; Maytansine; Mice; Pregnancy; Teniposide; Teratogens; Vincristine | 1978 |
Embryotoxicity of the intercalating agents m-AMSA and o-AMSA and the epipodophyllotoxin VP-16 in postimplantation rat embryos in vitro.
Topics: Abnormalities, Drug-Induced; Amsacrine; Animals; Antineoplastic Agents; DNA Damage; DNA Topoisomerases, Type II; Embryo, Mammalian; Etoposide; In Vitro Techniques; Intercalating Agents; Rats; Topoisomerase II Inhibitors | 1990 |